Sharifi‐Mood 2006.

Methods	Retrospective cohort study
Participants	29 confirmed cases Age 5 ‐ 17 years
Interventions	Early ribavirin (< 3 days) 30 mg/kg as an initial dose, then 15 mg/kg every 6 h for 4 days, then 7.5 mg/kg every 8 h for 6 days; Late ribavirin (> 3 days); Oral ribavirin
Outcomes	Mortality
Location and dates	Departments of Infectious Diseases, Boo‐Ali Hospital and Iman‐Ali Hospital in Zabol, Province: Sistan and Baluchistan (south‐east Iran), Province: Sistan and Baluchistan (south‐east Iran) tertiary centre June 1999 to February 2006
Number of days since onset of symptoms (mean/SD)	NR
Supportive therapy	NR
Notes	Study conducted only in children